Jump to Navigation
Trends and Sentiments
Comments and Analysis
London fintech startup iwoca just got $20 million from...
Best Frenemies: This Show Reveals The Surreal...
Gartman Is No Longer Bearish
Samsung Plans Galaxy S6 and S6 Edge Price Cut
Mr. Piggy Is Causing China Some Porky Problems
How Mark Hatch And TechShop Are Energizing American...
The South American Financial Crisis Of 2015
Can Journalists Be Too Skeptical About Progress Against...
Procter & Gamble Sales Fall for Sixth Straight Quarter
Facebook dominating ads: Analyst
China Biotech Week in Review: GSK Acquires Urology Drugmaker
Clinical Data: Highly Anticipated FDA Decision Could Revive Interest
Glaxo Goes on an Acquisition Spree
GlaxoSmithKline: An Atypical Dividend Investment
Ramius’ Persistence Pays Off: Cypress Biosciences Finally Says Yes - Biotech's Latest M&A Action
The Winner of ASH 2010: Seattle Genetics
India Markets Wednesday Wrap-Up: Negative Close as Banks Continue Slide
6 High Yield Pharmaceutical Companies: Do they Justify the Risk?
Top 19 Most Profitable Large Cap Stocks
20 Underperforming Stocks With a Track Record of Profitability
Life Sciences Deal Flows Boost Positive Mood at JPMorgan Healthcare Conference
Wall Street Breakfast: Must-Know News
Biotech Merger/Acquisition Activity Mixed During Major Conference
Glaxo's Latest $3.4 Billion Charge Over Avandia Reveals Costs of Misbehavior
GlaxoSmithKline: Latest Legal Charge Proves Very Costly
GSK Sets Aside $3.4 Billion Over Avandia Liabilities: Biotech's Latest Tribulations
Friday Options Recap
Arena Pharma Slashes Workforce by 25 Percent: Biotech's Latest Tribulations
GlaxoSmithKline PLC (ADR) CEO Discusses Q4 2010 Results - Earnings Call Transcript
15 British Stocks to Raise Dividend Payouts in 2011
Value Pharma Stocks in Overpriced Market
Jury Nails J&J With $482 Million Patent Infringement Verdict: Biotech's Latest Tribulations
A Look at Warren Buffett's 5 Highest Yielding Stock Holdings
Mannkind Slashes Staff: Biotech's Latest Tribulations
Ruble Extends Slide, Reviving Economic Concerns
US Economy Likely Rebounded to Solid Growth Rate...
EUR/GBP: 1.4273 USD/EUR: 1.0945 JPY/USD: 124.4250
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions